Pancreatic Cancer Detection Consortium
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Pancreatic Adenocarcinoma
Related studies linked through entity extraction aliases.
The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- NA
Multicenter Trial of ESK981 in Patients With Select Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Prospective Validation of an EHR-based Pancreatic Cancer Risk Model
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of LP-184 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Status
- RECRUITING
- Phase
- PHASE1
Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (Feasibility and Safety)
- Status
- RECRUITING
- Phase
- NA
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Personalized Vaccine With SOC Chemo Followed by Nivo in Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)
- Status
- COMPLETED
- Phase
- PHASE2